Average Co-Inventor Count = 11.63
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Novartis Ag (11 from 3,923 patents)
2. Novartis Vaccines & Diagnostics, Gmbh (3 from 245 patents)
14 patents:
1. 12252482 - Pyrazolopyridine derivatives and uses thereof
2. 12172984 - Pyrazolopyridine derivatives and uses thereof
3. 12071441 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
4. 11912715 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
5. 11787785 - Pyrazolopyridine derivatives and uses thereof
6. 11629149 - 10-(di(phenyl)methyl)-4-hydroxy-8,9,9A,10-tetrahydro-7H-pyrrolo[1',2′:4,5]pyrazino[1,2-b]pyridazine-3,5-dione derivatives and related compounds as inhibitors of the orthomyxovirus replication for treating influenza
7. 11453677 - Tricyclic compounds useful to treat orthomyxovirus infections
8. 11098051 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
9. 10858366 - Tricyclic compounds useful to treat orthomyxovirus infections
10. 10160764 - Fused tricyclic pyridazinone compounds useful to treat orthomyxovirus infections
11. 8735599 - Substituted imidazole derivates
12. 8318791 - Substituted imidazole derivatives
13. 7932262 - Quinazolines for PDK1 inhibition
14. 7576221 - Substituted imidazole derivatives